Article
Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma
12 Sept 2018
Abstract excerpt
Pluripotent cells have been used to probe developmental pathways that are involved in genetic diseases and oncogenic events. To find new therapies that would target MYB-driven tumors, we developed a pluripotent zebrafish blastomere culture system. We performed a chemical genetic screen and identified retinoic acid agonists as suppressors of c-myb expression. Retinoic acid treatment also decreased c-myb gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
